Human herpes viruses in burn patients: A systematic review

Burns. 2017 Feb;43(1):25-33. doi: 10.1016/j.burns.2016.02.003. Epub 2016 Aug 8.

Abstract

Objective: The contribution of human herpes viruses, including herpes simplex virus (HSV), cytomegalovirus (CMV), and varicella zoster virus (VZV) to morbidity and mortality after burns remains controversial. This systematic review was undertaken to assess evidence of herpes virus-related morbidity and mortality in burns.

Materials and methods: PubMed, Ovid, and Web of Science were searched to identify studies of HSV, CMV, or VZV infections in burn patients. Exclusion criteria included: A level of evidence (LoE) of IV or V; nonhuman in vivo studies; and non-English articles. There was no limitation by publication date.

Results: Fifty articles were subjected to full-text analysis. Of these, 18 had LoE between I-III and were included in the final review (2 LoE I, 16 LoE II-III). Eight had a prospective study design, 9 had a retrospective study design, and 1 included both.

Conclusions: No direct evidence linked CMV and HSV infection with increased morbidity and mortality in burns. Following burn, CMV reactivation was more common than a primary CMV infection. Active HSV infection impaired wound healing but was not directly correlated to mortality. Infections with VZV are rare after burns but when they occur, VZV infections were associated with severe complications including mortality. The therapeutic effect of antiviral agents administered after burns warrants investigation via prospective randomized controlled trials.

Keywords: Burns; Chickenpox; Cytomegalovirus; Herpes simplex virus; Human herpes virus; Varicella-zoster virus.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Antiviral Agents / therapeutic use
  • Burns / epidemiology
  • Burns / mortality
  • Burns / virology*
  • Chickenpox / drug therapy
  • Chickenpox / epidemiology*
  • Cytomegalovirus
  • Cytomegalovirus Infections / drug therapy
  • Cytomegalovirus Infections / epidemiology*
  • Herpes Simplex / drug therapy
  • Herpes Simplex / epidemiology*
  • Herpes Zoster / drug therapy
  • Herpes Zoster / epidemiology*
  • Herpesvirus 3, Human
  • Humans
  • Simplexvirus
  • Virus Activation

Substances

  • Antiviral Agents